Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Sales of Ethical Drugs Up 7.9% in June: Crecon
August 31, 2009
- Kowa Licenses Livalo to MTPC in Taiwan, Indonesia
August 31, 2009
- SELF-MEDICATION NEWS IN BRIEF
August 31, 2009
- DSP to Transform Itself into Global Research-Driven Pharma: President Tada
August 31, 2009
- G&G to Develop Overseas Business in Earnest
August 31, 2009
- Allopurinol + Uralyt Combination Useful for Management of MetS
August 31, 2009
- SSP to Place Top Priority on Operating Profit Rate
August 31, 2009
- R&D NEWS IN BRIEF
August 31, 2009
- REGULATORY NEWS IN BRIEF
August 31, 2009
- GE Healthcare Integrates Two Subsidiaries to Create GE Healthcare Japan
August 24, 2009
- AZ, Astellas to Copromote Symbicort in Japan
August 24, 2009
- SELF-MEDICATION NEWS IN BRIEF
August 24, 2009
- Daiichi Sankyo, Eli Lilly Launch Effient in the US
August 24, 2009
- JACDS Promotes Class 1 OTC Drugs to Increase Sales by 50%
August 24, 2009
- DSP to File NDA for Lurasidone in US in 1st Half of 2010
August 24, 2009
- Emergency Delivery Rates Achieve Goal at 83% in FY2008
August 24, 2009
- Zeria to Acquire Tillotts
August 24, 2009
- R&D NEWS IN BRIEF
August 24, 2009
- Cravit Tab 500 mg Prevents Emergence of Resistant Organisms: Daiichi Sankyo
August 24, 2009
- REGULATORY NEWS IN BRIEF
August 24, 2009
ページ
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…